Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.

Binderup T, Duivenvoorden R, Fay F, van Leent MMT, Malkus J, Baxter S, Ishino S, Zhao Y, Sanchez-Gaytan B, Teunissen AJP, Frederico YCA, Tang J, Carlucci G, Lyashchenko S, Calcagno C, Karakatsanis N, Soultanidis G, Senders ML, Robson PM, Mani V, Ramachandran S, Lobatto ME, Hutten BA, Granada JF, Reiner T, Swirski FK, Nahrendorf M, Kjaer A, Fisher EA, Fayad ZA, Pérez-Medina C, Mulder WJM.

Sci Transl Med. 2019 Aug 21;11(506). pii: eaaw7736. doi: 10.1126/scitranslmed.aaw7736.

PMID:
31434756
2.

Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R.

Nat Biomed Eng. 2018 Aug;2(8):623. doi: 10.1038/s41551-018-0281-3.

PMID:
31015637
3.

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R.

Nat Biomed Eng. 2018 May;2(5):279-292. doi: 10.1038/s41551-018-0221-2. Epub 2018 Apr 16. Erratum in: Nat Biomed Eng. 2018 Aug;2(8):623.

4.

Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance.

Braza MS, van Leent MMT, Lameijer M, Sanchez-Gaytan BL, Arts RJW, Pérez-Medina C, Conde P, Garcia MR, Gonzalez-Perez M, Brahmachary M, Fay F, Kluza E, Kossatz S, Dress RJ, Salem F, Rialdi A, Reiner T, Boros P, Strijkers GJ, Calcagno CC, Ginhoux F, Marazzi I, Lutgens E, Nicolaes GAF, Weber C, Swirski FK, Nahrendorf M, Fisher EA, Duivenvoorden R, Fayad ZA, Netea MG, Mulder WJM, Ochando J.

Immunity. 2018 Nov 20;49(5):819-828.e6. doi: 10.1016/j.immuni.2018.09.008. Epub 2018 Nov 6.

5.

Imaging Tropoelastin in Atherosclerosis.

Duivenvoorden R, Mulder WJM.

Circ Cardiovasc Imaging. 2018 Aug;11(8):e008147. doi: 10.1161/CIRCIMAGING.118.008147. No abstract available.

6.

Nanoimmunotherapy to treat ischaemic heart disease.

Duivenvoorden R, Senders ML, van Leent MMT, Pérez-Medina C, Nahrendorf M, Fayad ZA, Mulder WJM.

Nat Rev Cardiol. 2019 Jan;16(1):21-32. doi: 10.1038/s41569-018-0073-1. Review.

PMID:
30209355
7.

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.

Seijkens TTP, van Tiel CM, Kusters PJH, Atzler D, Soehnlein O, Zarzycka B, Aarts SABM, Lameijer M, Gijbels MJ, Beckers L, den Toom M, Slütter B, Kuiper J, Duchene J, Aslani M, Megens RTA, van 't Veer C, Kooij G, Schrijver R, Hoeksema MA, Boon L, Fay F, Tang J, Baxter S, Jongejan A, Moerland PD, Vriend G, Bleijlevens B, Fisher EA, Duivenvoorden R, Gerdes N, de Winther MPJ, Nicolaes GA, Mulder WJM, Weber C, Lutgens E.

J Am Coll Cardiol. 2018 Feb 6;71(5):527-542. doi: 10.1016/j.jacc.2017.11.055.

8.

CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease.

Verweij SL, Duivenvoorden R, Stiekema LCA, Nurmohamed NS, van der Valk FM, Versloot M, Verberne HJ, Stroes ESG, Nahrendorf M, Bekkering S, Bernelot Moens SJ.

Cardiovasc Res. 2018 Mar 1;114(3):468-475. doi: 10.1093/cvr/cvx224.

PMID:
29186373
9.

Manual versus Automated Carotid Artery Plaque Component Segmentation in High and Lower Quality 3.0 Tesla MRI Scans.

Smits LP, van Wijk DF, Duivenvoorden R, Xu D, Yuan C, Stroes ES, Nederveen AJ.

PLoS One. 2016 Dec 8;11(12):e0164267. doi: 10.1371/journal.pone.0164267. eCollection 2016.

10.

Immune cell screening of a nanoparticle library improves atherosclerosis therapy.

Tang J, Baxter S, Menon A, Alaarg A, Sanchez-Gaytan BL, Fay F, Zhao Y, Ouimet M, Braza MS, Longo VA, Abdel-Atti D, Duivenvoorden R, Calcagno C, Storm G, Tsimikas S, Moore KJ, Swirski FK, Nahrendorf M, Fisher EA, Pérez-Medina C, Fayad ZA, Reiner T, Mulder WJ.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6731-E6740. Epub 2016 Oct 17.

11.

Arterial and Cellular Inflammation in Patients with CKD.

Bernelot Moens SJ, Verweij SL, van der Valk FM, van Capelleveen JC, Kroon J, Versloot M, Verberne HJ, Marquering HA, Duivenvoorden R, Vogt L, Stroes ES.

J Am Soc Nephrol. 2017 Apr;28(4):1278-1285. doi: 10.1681/ASN.2016030317. Epub 2016 Oct 31.

12.

HDL mimetic CER-001 targets atherosclerotic plaques in patients.

Zheng KH, van der Valk FM, Smits LP, Sandberg M, Dasseux JL, Baron R, Barbaras R, Keyserling C, Coolen BF, Nederveen AJ, Verberne HJ, Nell TE, Vugts DJ, Duivenvoorden R, Fayad ZA, Mulder WJM, van Dongen GAMS, Stroes ESG.

Atherosclerosis. 2016 Aug;251:381-388. doi: 10.1016/j.atherosclerosis.2016.05.038. Epub 2016 May 27.

13.

In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S, Eldib M, Sánchez-Gaytán BL, Robson PM, Bini J, Granada JF, Fish KM, Stroes ES, Duivenvoorden R, Tsimikas S, Lewis JS, Reiner T, Fuster V, Kjær A, Fisher EA, Fayad ZA, Mulder WJ.

JACC Cardiovasc Imaging. 2016 Aug;9(8):950-61. doi: 10.1016/j.jcmg.2016.01.020. Epub 2016 May 25.

14.

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

Zhao Y, Fay F, Hak S, Manuel Perez-Aguilar J, Sanchez-Gaytan BL, Goode B, Duivenvoorden R, de Lange Davies C, Bjørkøy A, Weinstein H, Fayad ZA, Pérez-Medina C, Mulder WJ.

Nat Commun. 2016 Apr 13;7:11221. doi: 10.1038/ncomms11221.

15.

Unique Renal Manifestation of Type I Cryoglobulinemia, With Massive Crystalloid Deposits in Glomerular Histiocytes, Podocytes, and Endothelial Cells.

Hoelbeek J, Duivenvoorden R, de Boer OJ, Claessen N, Van den Bergh Weerman MA, Roelofs JJ, Kers J, Ten Berge IJ, Florquin S.

Am J Clin Pathol. 2016 Feb;145(2):282-5. doi: 10.1093/ajcp/aqv027. Epub 2016 Jan 21.

PMID:
26796493
16.

Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation.

Tang J, Lobatto ME, Hassing L, van der Staay S, van Rijs SM, Calcagno C, Braza MS, Baxter S, Fay F, Sanchez-Gaytan BL, Duivenvoorden R, Sager H, Astudillo YM, Leong W, Ramachandran S, Storm G, Pérez-Medina C, Reiner T, Cormode DP, Strijkers GJ, Stroes ES, Swirski FK, Nahrendorf M, Fisher EA, Fayad ZA, Mulder WJ.

Sci Adv. 2015 Apr;1(3). pii: e1400223.

17.

Increasing the Spatial Resolution of 3T Carotid MRI Has No Beneficial Effect for Plaque Component Measurement Reproducibility.

van Wijk DF, Strang AC, Duivenvoorden R, Enklaar DJ, Zwinderman AH, van der Geest RJ, Kastelein JJ, de Groot E, Stroes ES, Nederveen AJ.

PLoS One. 2015 Jul 10;10(7):e0130878. doi: 10.1371/journal.pone.0130878. eCollection 2015.

18.

Endothelial shear stress estimation in the human carotid artery based on Womersley versus Poiseuille flow.

Schwarz JC, Duivenvoorden R, Nederveen AJ, Stroes ES, VanBavel E.

Int J Cardiovasc Imaging. 2015 Mar;31(3):585-93. doi: 10.1007/s10554-014-0571-0. Epub 2014 Nov 18.

PMID:
25404081
19.

The value of screening for carotid plaque in patients referred for echocardiography.

Duivenvoorden R, Stroes ES, Hovingh GK.

Can J Cardiol. 2014 Oct;30(10):1148-9. doi: 10.1016/j.cjca.2014.07.001. Epub 2014 Jul 4. No abstract available.

PMID:
25154805
20.

A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.

Duivenvoorden R, Tang J, Cormode DP, Mieszawska AJ, Izquierdo-Garcia D, Ozcan C, Otten MJ, Zaidi N, Lobatto ME, van Rijs SM, Priem B, Kuan EL, Martel C, Hewing B, Sager H, Nahrendorf M, Randolph GJ, Stroes ES, Fuster V, Fisher EA, Fayad ZA, Mulder WJ.

Nat Commun. 2014;5:3065. doi: 10.1038/ncomms4065. Erratum in: Nat Commun. 2014;5:3531.

21.

Detection of liquid phase cholesteryl ester in carotid atherosclerosis by 1H-MR spectroscopy in humans.

Duivenvoorden R, van Wijk D, Klimas M, Kastelein JJ, Stroes ES, Nederveen AJ.

JACC Cardiovasc Imaging. 2013 Dec;6(12):1277-84. doi: 10.1016/j.jcmg.2013.03.010. Epub 2013 Oct 23.

22.

Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.

Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, Fayad ZA.

JACC Cardiovasc Imaging. 2013 Oct;6(10):1087-1094. doi: 10.1016/j.jcmg.2013.03.009.

23.

Increasing spatial resolution of 3T MRI scanning improves reproducibility of carotid arterial wall dimension measurements.

van Wijk DF, Strang AC, Duivenvoorden R, Enklaar DJ, van der Geest RJ, Kastelein JJ, de Groot E, Stroes ES, Nederveen AJ.

MAGMA. 2014 Jun;27(3):219-26. doi: 10.1007/s10334-013-0407-2. Epub 2013 Sep 18.

PMID:
24046072
24.

An accidental finding of multiple abdominal and pelvic tumours. Splenosis.

Duivenvoorden R, de Sonnaville JJ, van Muiswinkel JM.

Neth J Med. 2013 Sep;71(7):371, 375. No abstract available.

25.

ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden.

Bochem AE, van Wijk DF, Holleboom AG, Duivenvoorden R, Motazacker MM, Dallinga-Thie GM, de Groot E, Kastelein JJ, Nederveen AJ, Hovingh GK, Stroes ES.

Eur Heart J. 2013 Jan;34(4):286-91. doi: 10.1093/eurheartj/ehs376. Epub 2012 Nov 7.

PMID:
23136402
26.

Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness.

van den Bogaard B, Holleboom AG, Duivenvoorden R, Hutten BA, Kastelein JJ, Hovingh GK, Kuivenhoven JA, Stroes ES, van den Born BJ.

Atherosclerosis. 2012 Dec;225(2):481-5. doi: 10.1016/j.atherosclerosis.2012.09.022. Epub 2012 Sep 27.

27.

Safety of CETP inhibition.

Duivenvoorden R, Fayad ZA.

Curr Opin Lipidol. 2012 Dec;23(6):518-24. doi: 10.1097/MOL.0b013e32835916b3. Review.

PMID:
23010697
28.

Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging [corrected].

Duivenvoorden R, Holleboom AG, van den Bogaard B, Nederveen AJ, de Groot E, Hutten BA, Schimmel AW, Hovingh GK, Kastelein JJ, Kuivenhoven JA, Stroes ES.

J Am Coll Cardiol. 2011 Dec 6;58(24):2481-7. doi: 10.1016/j.jacc.2010.11.092. Erratum in: J Am Coll Cardiol. 2012 Jan 10;59(2):196.

29.

Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.

Bucerius J, Duivenvoorden R, Mani V, Moncrieff C, Rudd JH, Calcagno C, Machac J, Fuster V, Farkouh ME, Fayad ZA.

JACC Cardiovasc Imaging. 2011 Nov;4(11):1195-205. doi: 10.1016/j.jcmg.2011.07.008.

30.

Asymmetrical distribution of atherosclerosis in the carotid artery: identical patterns across age, race, and gender.

Tajik P, Meijer R, Duivenvoorden R, Peters SA, Kastelein JJ, Visseren FJ, Crouse JR 3rd, Palmer MK, Raichlen JS, Grobbee DE, Bots ML.

Eur J Prev Cardiol. 2012 Aug;19(4):687-97. doi: 10.1177/1741826711410821. Epub 2011 May 25.

PMID:
21613319
31.

Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies.

Duivenvoorden R, Fayad ZA.

Curr Atheroscler Rep. 2011 Jun;13(3):277-84. doi: 10.1007/s11883-011-0176-1. Review.

32.

Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation.

Kastelein JJ, Duivenvoorden R, Deanfield J, de Groot E, Jukema JW, Kaski JC, Münzel T, Taddei S, Lehnert V, Burgess T, Kallend D, Lüscher TF.

Curr Med Res Opin. 2011 Jan;27(1):141-50. doi: 10.1185/03007995.2010.536207. Epub 2010 Dec 6.

PMID:
21128879
33.

Molecular imaging: Measuring myocardial fatty acid metabolism with BMIPP SPECT.

Duivenvoorden R, Fayad ZA.

Nat Rev Cardiol. 2010 Dec;7(12):672-3. doi: 10.1038/nrcardio.2010.163. No abstract available.

PMID:
21102631
34.

Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia.

Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJ, Shear CL, Evans GW, Visseren FL, Bots ML; Radiance 1 and Radiance 2 Study Groups.

Ann Med. 2010 Sep;42(6):447-64. doi: 10.3109/07853890.2010.499132.

PMID:
20645885
35.

Endothelial shear stress: a critical determinant of arterial remodeling and arterial stiffness in humans--a carotid 3.0-T MRI study.

Duivenvoorden R, Vanbavel E, de Groot E, Stroes ES, Disselhorst JA, Hutten BA, Laméris JS, Kastelein JJ, Nederveen AJ.

Circ Cardiovasc Imaging. 2010 Sep;3(5):578-85. doi: 10.1161/CIRCIMAGING.109.916304. Epub 2010 Jun 24. Erratum in: Circ Cardiovasc Imaging. 2011 Mar 1;4(2):e3.

PMID:
20576811
36.

Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies.

Vergeer M, Zhou R, Bots ML, Duivenvoorden R, Koglin J, Akdim F, Mitchel YB, Huijgen R, Sapre A, de Groot E, Sijbrands EJ, Pasternak RC, Gagné C, Marais AD, Ballantyne CM, Isaacsohn JL, Stalenhoef AF, Kastelein JJ.

Circ Cardiovasc Imaging. 2010 Jul;3(4):398-404. doi: 10.1161/CIRCIMAGING.109.909655. Epub 2010 May 21.

PMID:
20494942
37.

Niacin compared with ezetimibe.

Duivenvoorden R, Vergeer M, Kastelein JJ.

N Engl J Med. 2010 Mar 18;362(11):1046-7; author reply 1048. No abstract available.

PMID:
20301795
38.

Completeness of carotid intima media thickness measurements depends on body composition: the RADIANCE 1 and 2 trials.

Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJ, Shear CL, Evans GW, Visseren FL, Bots ML; Radiance 1 and 2 Study Groups.

J Atheroscler Thromb. 2010 May;17(5):526-35. Epub 2010 Mar 13.

39.

In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging.

Duivenvoorden R, de Groot E, Elsen BM, Laméris JS, van der Geest RJ, Stroes ES, Kastelein JJ, Nederveen AJ.

Circ Cardiovasc Imaging. 2009 May;2(3):235-42. doi: 10.1161/CIRCIMAGING.108.788059. Epub 2009 Mar 19.

PMID:
19808598
40.

Comparison of in vivo carotid 3.0-T magnetic resonance to B-mode ultrasound imaging and histology in a porcine model.

Duivenvoorden R, de Groot E, Afzali H, Vanbavel ET, de Boer OJ, Laméris JS, Fayad ZA, Stroes ES, Kastelein JJ, Nederveen AJ.

JACC Cardiovasc Imaging. 2009 Jun;2(6):744-50. doi: 10.1016/j.jcmg.2008.12.030.

41.

Surrogate markers in clinical trials--challenges and opportunities.

Duivenvoorden R, de Groot E, Stroes ES, Kastelein JJ.

Atherosclerosis. 2009 Sep;206(1):8-16. doi: 10.1016/j.atherosclerosis.2008.12.009. Epub 2008 Dec 14. Review.

PMID:
19327774
42.

ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.

Meuwese MC, de Groot E, Duivenvoorden R, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA; CAPTIVATE Investigators.

JAMA. 2009 Mar 18;301(11):1131-9. doi: 10.1001/jama.301.11.1131.

PMID:
19293413
43.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E; ENHANCE Investigators.

N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30. Erratum in: N Engl J Med. 2008 May 1;358(18):1977.

44.

Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis.

de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML, Kastelein JJ.

Nat Clin Pract Cardiovasc Med. 2008 May;5(5):280-8. doi: 10.1038/ncpcardio1163. Epub 2008 Mar 11. Review.

PMID:
18332891
45.

Atherosclerosis imaging as a benchmark in the development of novel cardiovasular drugs.

Duivenvoorden R, Nederveen AJ, de Groot E, Kastelein JJ.

Curr Opin Lipidol. 2007 Dec;18(6):613-21. Review.

PMID:
17993805

Supplemental Content

Loading ...
Support Center